Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CA 4. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Efficient iron-catalyzed synthesis of 3-aroylindanone-2-carboxylates offering cost reduction and scalable pharmaceutical intermediate manufacturing solutions.
Patent CN113880720A reveals a novel FeCl3-catalyzed reduction for Mirabegron intermediates, offering significant cost reduction and enhanced safety for API manufacturing supply chains.
Novel dehydration-epoxidation route for Delta9,11-canrenone achieves >80% yield. Reduces steps vs fermentation. Ideal for eplerenone manufacturing.
Novel Ru-catalyzed route for (S)-duloxetine intermediate offers high ee and yield without nitrogen protection, reducing manufacturing costs.
Novel chiral synthesis route for octahydro-2H-pyrrolo[3,4-c]pyridine derivatives offering high purity and scalable pharmaceutical intermediate production capabilities.
Patent CN110981823B reveals high-purity triazole synthesis. Achieve significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN106008453B reveals green hydrogenation method. Reduces waste, ensures high purity, offers cost-effective supply chain solutions for pharma intermediates.
Patent CN103130708B reveals high-yield synthesis route for Boc-4-nitropiperidine intermediates offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel aniline-based route for 4,4'-diaminodiphenyl ether. Reduces cost and pollution. Reliable supply for polymer and pharma applications.
Novel 2-step route for Selpercatinib via CN111057075B. High purity >99.5%, mild conditions, cost-effective manufacturing for RET inhibitors.
Novel manganese-catalyzed process for carfilzomib intermediates significantly reduces cost and waste. Reliable pharmaceutical intermediate supplier for global scale manufacturing.
Patent CN102070611A reveals a high-yield, two-step Hantzsch route for amlodipine intermediates, offering significant cost reduction and scalable manufacturing for global API producers.
Patent CN105037420A details mild Pd-catalyzed synthesis. Enables high-purity pharmaceutical intermediates with scalable cost reduction and supply reliability.
Novel patent CN110028461A enables high-purity candesartan cilexetil production with improved supply chain stability and significant cost efficiency for global buyers.
Novel route for 4-trifluoromethyl nicotinic acid offers cost reduction and supply reliability for agrochemical manufacturing partners seeking high-purity intermediates.
Novel halogenation-fluorination route for 5-fluoro-2-hydroxyacetophenone. High yield, low waste, scalable process for beta-blocker intermediates.
Patent CN104016974A details a novel synthetic route for Azilsartan medoxomil intermediates, offering high purity and significant cost reduction opportunities for pharmaceutical manufacturing supply chains.
Novel patent CN114044813B details high-yield procatide preparation offering supply chain stability and significant cost reduction in API manufacturing for global partners.
Patent CN114230568B details a high-yield 4-step route for HER2 inhibitor Tucatinib using Pd(acac)2, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN114230568B reveals a high-yield route for HER2 inhibitor Tucatinib. Discover cost-effective manufacturing and scalable purification strategies for pharma intermediates.